0 Comments
0 Shares
3326 Views
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 Comments 0 Shares 3242 Views
- CAR-T Cell Therapy Market Size, Share, Growth Analysis and Forecast 2022–2030The CAR-T Cell Therapy Market is experiencing remarkable growth as advanced immunotherapy solutions continue to transform cancer treatment worldwide. Chimeric Antigen Receptor T-cell therapy has emerged as one of the most innovative approaches in oncology, offering personalized treatment options for patients with certain blood cancers. Rising incidences of leukemia, lymphoma, and multiple...0 Comments 0 Shares 1463 Views
- Global Bispecific T-Cell Engager (BiTE) Therapeutics Market: 15.8% CAGR to Reach USD 20.1 Billion by 2032According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 Comments 0 Shares 1659 Views
- Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Comments 0 Shares 873 Views
- Global gene therapy for ovarian cancer market growth outlook with 15.8% CAGR (2025–2031)According to a newly published market research report by 24LifeSciences, global gene therapy for ovarian cancer market was valued at USD 423.7 million in 2024 and is projected to reach USD 1.12 billion by 2031, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 2025-2031. Gene therapy represents a revolutionary treatment paradigm for ovarian cancer, leveraging...0 Comments 0 Shares 3070 Views
- Global TIL Cell Therapy Market: 43.3% CAGR to Reach USD 1.12 Billion by 2034According to a newly published market research report by 24LifeSciences, global TIL cell therapy market was valued at USD 100 million in 2025 and is projected to reach USD 1,116 million by 2034, growing at a compound annual growth rate (CAGR) of 43.3% during the forecast period 2026-2034. Tumor-Infiltrating Lymphocyte (TIL) therapy represents a breakthrough in adoptive cell therapy for advanced...0 Comments 0 Shares 1653 Views
- How Is Transport E-Toll Market Supporting Smart Transportation and Traffic Management Systems?According to the latest report published by Data Bridge Market Research, the Transport E-Toll Market CAGR Value The global Transport E-Toll market size was valued at USD 13.53 billion in 2025 and is expected to reach USD 29.44 billion by 2033, at a CAGR of 10.20% during the forecast period Winning Transport E-Toll Marketresearch report deeply analyses the potential of the market...0 Comments 0 Shares 1388 Views
- Next-Generation Imaging Technologies Reshaping the Future of Photoacoustic DiagnosticsPhotoacoustic Imaging Market Summary: According to the latest report published by Data Bridge Market Research, the Photoacoustic Imaging Market CAGR Value The global photoacoustic imaging market size was valued at USD 180.13 million in 2024 and is expected to reach USD 709.92 million by 2032, at a CAGR of 18.70% during the forecast period This Photoacoustic Imaging...0 Comments 0 Shares 930 Views
- United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Comments 0 Shares 2266 Views
More Results